Annual report pursuant to Section 13 and 15(d)

Note Receivable

v3.21.1
Note Receivable
12 Months Ended
Dec. 31, 2020
Receivables [Abstract]  
Note Receivable

13. Note Receivable

 

On October 1, 2018, the Company completed the sale of its spine implant business to CTL Medical. The sale included a $6 million noninterest bearing note receivable payable over a 36 month term, with maturing of the note receivable on October 1, 2021. The note receivable includes an imputed interest rate of 10%. As of December 31, 2020, the net carrying value of the note receivable was $1.9  million, with expected cash proceeds of $1.9  million.